WASHINGTON — The U.S. Food and Drug Administration approved on Tuesday Allegra allergy medications for over-the-counter sale in adults and children 2 years of age and older beginning in March.
Additionally, Allegra-D, which also relieves nasal congestion and sinus pressure, also will be sold without a prescription at the pharmacy counter for use in adults and children 12 years of age and older.
Paris-based drugmaker Sanofi-Aventis has seen prescription sales of its blockbuster allergy drug tumble since generic versions began appearing on the market in 2005 when prescription sales of Allegra topped $1.1 billion euros, according to reports.
